Item 5.07 Submission of Matters to a Vote of Security Holders.

The Cigna Group (the "Company") held its Annual Meeting of Shareholders on April 26, 2023 (the "Annual Meeting"). Of the 297,032,506 shares outstanding and entitled to vote, 270,055,010 shares, or 90.92%, were represented in person or by proxy at the Annual Meeting. The results for each of the proposals submitted to a vote of our shareholders at the Annual Meeting are set forth below. Each proposal is described in more detail in our 2023 Proxy Statement, filed with the Securities and Exchange Commission on March 17, 2023.



Proposal 1: Shareholders elected the eleven director nominees named in the 2023
Proxy Statement for one-year terms to expire at the next annual meeting of
shareholders.



                                                                                 Broker
Nominees                               Votes For   Votes Against Abstentions   Non-Votes
David M. Cordani                       235,236,359   15,494,846    1,008,376   18,315,429
William J. DeLaney                     247,755,955   3,682,674      300,952    18,315,429
Eric J. Foss                           239,563,836   11,872,228     303,517    18,315,429

Elder Granger, M.D., MG, USA, Retired 248,018,332 3,427,892 293,357 18,315,429 Neesha Hathi

                           250,261,620   1,182,810      295,151    18,315,429
George Kurian                          247,075,171   4,363,507      300,903    18,315,429
Kathleen M. Mazzarella                 240,419,377   11,047,115     273,089    18,315,429
Mark B. McClellan, M.D., Ph.D.         248,378,860   3,073,143      287,578    18,315,429
Kimberly A. Ross                       249,619,856   1,845,221      274,504    18,315,429
Eric C. Wiseman                        244,478,214   6,965,820      295,547    18,315,429
Donna F. Zarcone                       234,520,003   16,951,139     268,439    18,315,429

In addition, shareholders voted on the following proposals and cast their votes as described below.

Proposal 2: Advisory approval of The Cigna Group's executive compensation.

Votes For Votes Against Abstentions Broker Non-Votes 221,436,565 29,691,242 611,774 18,315,429

Proposal 3: Advisory approval of the frequency of future advisory votes on executive compensation.





 One Year   Two Years Three Years Abstentions
247,538,876  179,056   3,654,770    366,879

Based on the results of the vote, and consistent with the recommendation of the Board of Directors of the Company (the "Board"), the Board has determined that future non-binding votes of shareholders to approve the compensation of the named executive officers will be submitted annually to the Company's shareholders until the next non-binding shareholder vote on the frequency of shareholder votes on executive compensation, or until the Board otherwise determines a different frequency for such non-binding votes.

Proposal 4: Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2023.





 Votes For  Votes Against Abstentions
252,867,500  16,905,824     281,686

Proposal 5: Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law.

Votes For Votes Against Abstentions Broker Non-Votes 222,860,732 28,396,757 482,092 18,315,429

Proposal 6: Shareholder Proposal - Special shareholder meeting improvement.

Votes For Votes Against Abstentions Broker Non-Votes 117,434,728 133,649,193 655,660 18,315,429

© Edgar Online, source Glimpses